Terms: = Head and neck cancer AND DEK, D6S231E, 7913, ENSG00000124795, P35659
34 results:
1. Re-evaluating a historic cohort of sinonasal and skull base mucoepidermoid carcinoma: an institutional experience.
Hu C; Lin L; Ye M; Liu Y; Huang Q; Yuan C; Sun J; Sun H
Diagn Pathol; 2024 Mar; 19(1):46. PubMed ID: 38429827
[TBL] [Abstract] [Full Text] [Related]
2. A diagnostic algorithm for sinonasal papillary non-keratinizing squamous cell carcinoma with dek::AFF2 fusion and mimickers.
Laforga JB; Othman BK
Rev Esp Patol; 2024; 57(1):67-70. PubMed ID: 38246714
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence and interpretation of AFF immunostain of dek::AFF2 fusion-associated papillary squamous cell carcinoma in a retrospective cohort of recurrent sinonasal papillomas.
Ng JKM; Chow C; Tang CY; Chan AZ; Li JJX; Chan ABW
Virchows Arch; 2024 Jan; 484(1):119-125. PubMed ID: 38063896
[TBL] [Abstract] [Full Text] [Related]
4. The First Report of Cytology of dek::AFF2 Fusion-Associated Papillary Squamous Cell Carcinoma on Fine-Needle Aspiration.
Li JJX; Ng JKM; Chan ABW
Head Neck Pathol; 2023 Dec; 17(4):1058-1063. PubMed ID: 37938508
[TBL] [Abstract] [Full Text] [Related]
5. Detection of salivary gland and sinonasal fusions by a next-generation sequencing based, ligation-dependent, multiplex RT-PCR assay.
Lanic MD; Guérin R; Wassef M; Durdilly P; Rainville V; Sater V; Jardin F; Ruminy P; Costes-Martineau V; Laé M
Histopathology; 2023 Nov; 83(5):685-699. PubMed ID: 37350081
[TBL] [Abstract] [Full Text] [Related]
6. [Sinonasal neoplasms: Update from the WHO 2022].
Agaimy A
Pathologie (Heidelb); 2023 Jul; 44(4):233-239. PubMed ID: 37286851
[TBL] [Abstract] [Full Text] [Related]
7. Differentiated Papillary NUT Carcinoma: An Unexpected, Deceptively Bland Presentation of a Sinonasal Carcinoma.
Wartenberg M; Hool SL; Marrazzini A; Giger R; Rupp NJ
Head Neck Pathol; 2023 Sep; 17(3):803-807. PubMed ID: 37118352
[TBL] [Abstract] [Full Text] [Related]
8. Challenging differential diagnoses in small biopsies from the sinonasal tract.
Israel AK; Cracolici V; Griffith CC
Semin Diagn Pathol; 2023 Sep; 40(5):321-332. PubMed ID: 37085435
[TBL] [Abstract] [Full Text] [Related]
9. Low-grade papillary Schneiderian carcinoma with TP53 mutation: a case report and review of the literature.
Yuzawa S; Michizuka T; Kakisaka R; Ono Y; Hayashi M; Takahara M; Katada A; Mizukami Y; Tanino M
Diagn Pathol; 2023 Apr; 18(1):44. PubMed ID: 37041626
[TBL] [Abstract] [Full Text] [Related]
10. Sinonasal Adenosquamous Carcinoma - Morphology and Genetic Drivers Including Low- and High-Risk Human Papillomavirus mRNA, dek::AFF2 Fusion, and MAML2 Rearrangement.
Holliday D; Mehrad M; Ely KA; Tong F; Wang X; Hang JF; Kuo YJ; Velez-Torres JM; Lott-Limbach A; Lewis JS
Head Neck Pathol; 2023 Jun; 17(2):487-497. PubMed ID: 36849671
[TBL] [Abstract] [Full Text] [Related]
11. Translocations and Gene Fusions in Sinonasal Malignancies.
Larkin R; Hermsen MA; London NR
Curr Oncol Rep; 2023 Apr; 25(4):269-278. PubMed ID: 36753024
[TBL] [Abstract] [Full Text] [Related]
12. dek::AFF2 Fusion Carcinomas of head and neck.
Ruangritchankul K; Sandison A
Adv Anat Pathol; 2023 Mar; 30(2):86-94. PubMed ID: 36221219
[TBL] [Abstract] [Full Text] [Related]
13. CD163 Immunohistochemical "Circle Sign" Staining Pattern Differentiates Sinonasal Papillomas From Morphologically Similar Non-neoplastic Lesions.
Sterling BC; Mehrad M; Ely KA; Lewis JS
Am J Surg Pathol; 2022 Nov; 46(11):1507-1513. PubMed ID: 35993580
[TBL] [Abstract] [Full Text] [Related]
14. p21-activated kinase 2 binds to transcription factor SOX2 and up-regulates dek to promote the progression of lung squamous cell carcinoma.
Xie S; Wan X; Chen S; Hu Y; Liu X
Lab Invest; 2022 Oct; 102(10):1109-1120. PubMed ID: 35821094
[TBL] [Abstract] [Full Text] [Related]
15. First Report of Thoracic Carcinoma With dek::AFF2 Rearrangement: A Case Report.
Savari O; Chang JC; Bishop JA; Sakthivel MK; Askin FB; Rekhtman N
J Thorac Oncol; 2022 Aug; 17(8):1050-1053. PubMed ID: 35773081
[TBL] [Abstract] [Full Text] [Related]
16. Unclassified Neuroendocrine Tumor with a Novel CHD4::AFF2 Fusion: Expanding the Family of AFF2-Rearranged head and neck Malignancies.
Miller DL; Palsgrove DN; Rijal A; Hathuc V; Chernock R; Gagan J; Bishop JA
Head Neck Pathol; 2022 Sep; 16(3):928-933. PubMed ID: 35218513
[TBL] [Abstract] [Full Text] [Related]
17. dek-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology.
Kuo YJ; Lewis JS; Zhai C; Chen YA; Chernock RD; Hsieh MS; Lan MY; Lee CK; Weinreb I; Hang JF
Mod Pathol; 2021 Oct; 34(10):1820-1830. PubMed ID: 34108636
[TBL] [Abstract] [Full Text] [Related]
18. dek-AFF2 Carcinoma of the Sinonasal Region and Skull Base: Detailed Clinicopathologic Characterization of a Distinctive Entity.
Rooper LM; Agaimy A; Dickson BC; Dueber JC; Eberhart CG; Gagan J; Hartmann A; Khararjian A; London NR; MacMillan CM; Palsgrove DN; Nix JS; Sandison A; Stoehr R; Truong T; Weinreb I; Bishop JA
Am J Surg Pathol; 2021 Dec; 45(12):1682-1693. PubMed ID: 34049316
[TBL] [Abstract] [Full Text] [Related]
19. Middle Ear and Temporal Bone Nonkeratinizing Squamous Cell Carcinomas With dek-AFF2 Fusion: An Emerging Entity.
Todorovic E; Truong T; Eskander A; Lin V; Swanson D; Dickson BC; Weinreb I
Am J Surg Pathol; 2020 Sep; 44(9):1244-1250. PubMed ID: 32366754
[TBL] [Abstract] [Full Text] [Related]
20. Promotion of cell proliferation by the proto-oncogene dek enhances oral squamous cell carcinogenesis through field cancerization.
Nakashima T; Tomita H; Hirata A; Ishida K; Hisamatsu K; Hatano Y; Kanayama T; Niwa A; Noguchi K; Kato K; Miyazaki T; Tanaka T; Shibata T; Hara A
Cancer Med; 2017 Oct; 6(10):2424-2439. PubMed ID: 28834425
[TBL] [Abstract] [Full Text] [Related]
[Next]
